OverviewSuggest Edit

Olainfarm manufactures and distributes chemical and pharmaceutical products. The company operates through five segments: medicine production, chemicals, wholesale, retail, compression materials, and others. It provides over the counter and prescription medicines, including anti-allergy, anti-inflammatory and analgesic, antibacterial, common cold, digestive system, metabolic, antifungal, and antiviral, as well as medicines for cardiovascular health, digestive and nervous systems, food supplements. Olainfarm also offers active pharmaceutical ingredients (APIs) and intermediates, pharmacovigilance services for patients and other stakeholders, as well as physicians and pharmacists, QC/QA, regulatory, APIs and intermediates development, final dosage forms development, and contract manufacturing services.

TypePublic
Founded1972
HQOlaine, LV
Websitelv.olainfarm.com

Latest Updates

Employees (est.) (Jul 2021)2,191(+2%)
Share Price (Nov 2021)€9.3
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Olainfarm

Vladimirs Krušinskis

Vladimirs Krušinskis

Director of the Technical Department
Jeroen Weites

Jeroen Weites

Chairman of the Board
Genadijs Melnis

Genadijs Melnis

Director of the Administrative Department
Vjačeslavs Krauklis

Vjačeslavs Krauklis

Director of the Manufacturing Department
Zane Kotāne

Zane Kotāne

Member of the Board (CFO)
Gita Siliņa

Gita Siliņa

Director of the Department of Medicine and Regulatory Affairs
Show more

Olainfarm Office Locations

Olainfarm has an office in Olaine
Olaine, LV (HQ)
5 Rūpnīcu iela
Show all (4)

Olainfarm Financials and Metrics

Olainfarm Revenue

Market capitalization (10-Nov-2021)

130.4m

Closing stock price (10-Nov-2021)

9.3
Olainfarm's current market capitalization is €130.4 m.
Show all financial metrics

Olainfarm Online and Social Media Presence

Embed Graph

Olainfarm News and Updates

AS AB CITY starts the mandatory buy-back of AS Olainfarm shares

In accordance with a decision by the majority of shareholders at the AS Olainfarm Extraordinary Meeting of Shareholders held on 14 October 2021, AS Olainfarm shares are being delisted from the regulated market, and the company’s shares will no longer be traded on the NASDAQ Riga Stock Exchange. In o…

On transactions with JSC Olainfarm shares

On October 8th, 2021 notifications regarding transfers of shares has been received from Irina Maligina and OU "Olfim", which is a closely related party to Irina Maligina who performs manager's duties at JSC Olainfarm.

Ten new products every year: Olainfarm masterplans future gains in Central and Eastern Europe

By investing EUR 100 million over a five year period and developing ten new products a year, AS Olainfarm plans to become one of the top 10 pharmaceutical companies in Central and Eastern Europe.

In H1 2021 Olainfarm Group continues stable growth

The compiled financial indicators for the first six months of this year confirm the growth of Olainfarm Group. The financial performance measures of both Olainfarm and its subsidiaries have grown steadily, compared to the same period last year, which means that we are heading in the right direction.…

Olainfarm invites to Second Quarter 2021 Investor Conference Webinar

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on August 31, 2021 at 04:00 PM (EEST). To join the webinar please follow the instructions below.

On legal proceedings related to the mandatory share repurchase offer of JSC Olainfarm

Joint Stock Company Olainfarm, hereinafter - the Company, hereby informs that it has been invited as a third party in the administrative case No A43003521, hereinafter - the Case, initiated in regard to the application of Agris Auce and Mārcis Judzis, shareholders of JSC Olainfarm, dated 26 July 202…
Show more

Olainfarm Blogs

A long-term strategy and clear priorities are required for development in pharmacy

When considering different aspects, it is clear that the health and pharmacy field requires a strategic national vision in order to develop and grow – Juris Bundulis, the new Chairman of the Supervisory Council of JSC Olainfarm, tells Dienas Bizness in an interview. You have recently become the new …

Notification on convocation of the Joint Stock Company Olainfarm Extraordinary General Meeting of Shareholders

The Management Board of joint stock company Olainfarm, registration number: 40003007246, legal address: Rūpnīcu iela 5, Olaine, LV-2114, Latvia (hereafter – the Company) based on the request of the shareholder SIA “OLMAFARM”, registration number: 40003283699, legal address: Tērbatas iela 74A, Rīga, …

Olainfarm Group invites to participate in voting for the Annual Prize in Medicine 2020

The post Olainfarm Group invites to participate in voting for the Annual Prize in Medicine 2020 appeared first on Joint Stock Company Olainfarm.

JSC Olainfarm donates funds to the Children’s Hospital Foundation for the purchase of new mattresses

The post JSC Olainfarm donates funds to the Children’s Hospital Foundation for the purchase of new mattresses appeared first on Joint Stock Company Olainfarm.

JSC Olainfarm donates funds to the National reference laboratory of Riga East Hospital for the purchase of Covid-19 analysis equipment

The post JSC Olainfarm donates funds to the National reference laboratory of Riga East Hospital for the purchase of Covid-19 analysis equipment appeared first on Joint Stock Company Olainfarm.

“Olainfarm” confirmed the compliance with Russian Good Manufacturing Practice (GMP)

The post “Olainfarm” confirmed the compliance with Russian Good Manufacturing Practice (GMP) appeared first on Joint Stock Company Olainfarm.
Show more

Olainfarm Frequently Asked Questions

  • When was Olainfarm founded?

    Olainfarm was founded in 1972.

  • Who are Olainfarm key executives?

    Olainfarm's key executives are Vladimirs Krušinskis, Jeroen Weites and Genadijs Melnis.

  • How many employees does Olainfarm have?

    Olainfarm has 2,191 employees.

  • Who are Olainfarm competitors?

    Competitors of Olainfarm include Amarna Therapeutics, Biosearch Life and Cue Biopharma.

  • Where is Olainfarm headquarters?

    Olainfarm headquarters is located at 5 Rūpnīcu iela, Olaine.

  • Where are Olainfarm offices?

    Olainfarm has an office in Olaine.

  • How many offices does Olainfarm have?

    Olainfarm has 4 offices.